Epilepsy-Associated Stigma (EPISTIGMA)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Few data about epilepsy-associated stigma in France are available. The only study we have found showed that in France 66% of people with epilepsy felt stigmatized by their condition and are often single, compared with the other European patients interviewed (Baker et al., 2000). The purpose of this study is to assess the association between type of epilepsy (drug resistant-epilepsy and stabilized epilepsy) and perceived stigma (using the Stigma Scale) in patients recruited in the Limousin region .
| Condition |
|---|
|
Epilepsy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | EPILEPSY-ASSOCIATED STIGMA AND ILLNESS EXPERIENCE IN PEOPLE WITH EPILEPSY |
- score of perceived stigma [ Time Frame: Day one ] [ Designated as safety issue: No ]
This scale estimates a score of perceived stigma for each individual and allows classifying individuals in 3 categories.
Thus, individuals who obtain a total score of 0 will be those who do not feel stigmatized. Those whose scores will be over or equal to 1will be those who feel stigmatized. Finally, respondents whose the score is equal to 3 will be considered as having a strong perception of stigma.
A positive response is characterized by threshold ≥ 1.
- Evaluation of the illness experience will be performed by the first section of the EMIC. [ Designated as safety issue: No ]
- Evaluation of the representations of epilepsy (perceived causes) will be done by the second section of the EMIC [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
Epilepsy-associated stigma leads important problems in terms of public health because it can provoke significant cognitive repercussions, impairment of quality of life and it causes physical injuries and serious disabilities. These social consequences often cause more suffering for patients than seizures themselves.
This heavy medical and social burden is associated with significant economic cost in terms of care and disability. It is also noted that mortality rate is 2 to 10 times higher than the general population.
It is therefore urgent to consider both medical and social dimension of consequences of epilepsy especially in patients with uncontrolled seizures.
It is also essential to detect a potential psychiatric disorder associated with epilepsy, especially depression and anxiety which are the most prevalent psychiatric comorbidities. These disorders are often under-diagnosed that can frequently leads to an inappropriate care.
The purpose of this study is to assess the association between type of epilepsy (drug resistant-epilepsy and stabilized epilepsy) and perceived stigma (using the Stigma Scale) in patients recruited in the Limousin region .
The primary outcome will be the score of perceived stigma obtained from the Stigma Scale.
This scale estimates a score of perceived stigma for each individual and allows classifying individuals in 3 categories.
Thus, individuals who obtain a total score of 0 will be those who do not feel stigmatized. Those whose scores will be over or equal to 1will be those who feel stigmatized. Finally, respondents whose the score is equal to 3 will be considered as having a strong perception of stigma.
A positive response is characterized by threshold ≥ 1.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
This is a, descriptive and analytical study, based on a semi-directive interview among people suffering from epilepsy.
Inclusion Criteria:
- 18 years and above
- diagnosed by a neurologist as suffering from drug-resistant epilepsy (all types of seizures) outpatient in Neurology service of the investigation centres
- inhabitant in the Limousin region
- having signed the informed consent
- affiliated or profiting of a social security system
Exclusion Criteria:
- patients that are deprived of their freedom
- patients with disabilities
- patients suffering from a chronic or an acute delusional disorder
- patients suffering from others handicaps
Contacts and Locations| Contact: Pierre Marie PREUX, MD | 05 55 43 59 84 | preux@unilim.fr |
| Contact: Rafaella FLORENTINA, PhD | florentina.rafael@hotmail.fr |
| France | |
| Service de neurologie | Recruiting |
| Limoges, France, 87042 | |
| Contact: Bertrand GODET, MD 05 55 05 55 55 bertrand.godet@unilim.fr | |
| Principal Investigator: Bertrand GODET, MD | |
| Sub-Investigator: Maryse TUILLAS, MD | |
More Information
No publications provided
| Responsible Party: | University Hospital, Limoges |
| ClinicalTrials.gov Identifier: | NCT01374204 History of Changes |
| Other Study ID Numbers: | I09004 |
| Study First Received: | June 14, 2011 |
| Last Updated: | February 27, 2013 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by University Hospital, Limoges:
|
Epilepsy Stigma |
Additional relevant MeSH terms:
|
Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013